| Literature DB >> 20549467 |
Abstract
The induction of pluripotency in somatic cells is widely considered as a major breakthrough in regenerative medicine, because this approach provides the basis for individualized stem cell-based therapies. Moreover, with respect to cell transplantation and tissue engineering, expertise from bioengineering to transplantation medicine is now meeting basic research of stem cell biology.In this chapter, we discuss techniques, potential and possible risks of induced pluripotent stem (iPS) cells in the light of needs for patient-derived pluripotent stem cells. To this end, we compare these cells with other sources of pluripotent cells and discuss the first encouraging results of iPS cells in pharmacological research, disease modeling and cell transplantation, providing fascinating perspectives for future developments in biotechnology and regenerative medicine.Entities:
Mesh:
Year: 2010 PMID: 20549467 DOI: 10.1007/10_2010_74
Source DB: PubMed Journal: Adv Biochem Eng Biotechnol ISSN: 0724-6145 Impact factor: 2.635